Foro de Residentes
FR - Nuevas indicaciones de nicotinamida en dermatología
Nicotinamide: New Indications in Dermatology
Leído
24844
Vecesse ha leído el artículo
2935
Total PDF
21909
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 264 | 37 | 301 |
| 2025 5 | 380 | 43 | 423 |
| 2025 4 | 401 | 32 | 433 |
| 2025 3 | 578 | 64 | 642 |
| 2025 2 | 542 | 57 | 599 |
| 2025 1 | 819 | 41 | 860 |
| 2024 12 | 811 | 42 | 853 |
| 2024 11 | 497 | 91 | 588 |
| 2024 10 | 531 | 79 | 610 |
| 2024 9 | 584 | 39 | 623 |
| 2024 8 | 755 | 70 | 825 |
| 2024 7 | 479 | 44 | 523 |
| 2024 6 | 434 | 55 | 489 |
| 2024 5 | 369 | 52 | 421 |
| 2024 4 | 377 | 45 | 422 |
| 2024 3 | 510 | 47 | 557 |
| 2024 2 | 416 | 46 | 462 |
| 2024 1 | 508 | 41 | 549 |
| 2023 12 | 427 | 40 | 467 |
| 2023 11 | 507 | 47 | 554 |
| 2023 10 | 549 | 40 | 589 |
| 2023 9 | 625 | 32 | 657 |
| 2023 8 | 453 | 22 | 475 |
| 2023 7 | 453 | 38 | 491 |
| 2023 6 | 496 | 42 | 538 |
| 2023 5 | 482 | 36 | 518 |
| 2023 4 | 367 | 37 | 404 |
| 2023 3 | 288 | 47 | 335 |
| 2023 2 | 310 | 49 | 359 |
| 2022 1 | 296 | 28 | 324 |
| 2022 12 | 185 | 36 | 221 |
| 2022 11 | 232 | 42 | 274 |
| 2022 10 | 232 | 52 | 284 |
| 2022 9 | 214 | 70 | 284 |
| 2022 8 | 205 | 48 | 253 |
| 2022 7 | 173 | 47 | 220 |
| 2022 6 | 192 | 41 | 233 |
| 2022 5 | 186 | 55 | 241 |
| 2022 4 | 213 | 40 | 253 |
| 2022 3 | 249 | 59 | 308 |
| 2022 2 | 240 | 45 | 285 |
| 2021 1 | 239 | 47 | 286 |
| 2021 12 | 190 | 43 | 233 |
| 2021 11 | 218 | 56 | 274 |
| 2021 10 | 280 | 61 | 341 |
| 2021 9 | 233 | 70 | 303 |
| 2021 8 | 319 | 44 | 363 |
| 2021 7 | 361 | 44 | 405 |
| 2021 6 | 282 | 43 | 325 |
| 2021 5 | 240 | 55 | 295 |
| 2021 4 | 1071 | 88 | 1159 |
| 2021 3 | 296 | 49 | 345 |
| 2021 2 | 233 | 39 | 272 |
| 2020 1 | 158 | 36 | 194 |
| 2020 12 | 160 | 39 | 199 |
| 2020 11 | 94 | 24 | 118 |
| 2020 10 | 100 | 30 | 130 |
| 2020 9 | 74 | 22 | 96 |
| 2020 8 | 70 | 21 | 91 |
| 2020 7 | 74 | 23 | 97 |
| 2020 6 | 49 | 31 | 80 |
| 2020 5 | 54 | 28 | 82 |
| 2020 4 | 46 | 22 | 68 |
| 2020 3 | 43 | 19 | 62 |
| 2020 2 | 4 | 2 | 6 |
| 2019 11 | 1 | 0 | 1 |
| 2019 10 | 1 | 0 | 1 |
| 2019 9 | 5 | 0 | 5 |
| 2019 8 | 1 | 0 | 1 |
| 2019 5 | 0 | 1 | 1 |
| 2019 4 | 2 | 4 | 6 |
| 2019 2 | 5 | 4 | 9 |
| 2019 1 | 1 | 2 | 3 |
| 2018 12 | 2 | 2 | 4 |
| 2018 11 | 1 | 0 | 1 |
| 2018 10 | 2 | 2 | 4 |
| 2018 9 | 5 | 1 | 6 |
| 2018 7 | 2 | 0 | 2 |
| 2018 6 | 2 | 0 | 2 |
| 2018 5 | 1 | 0 | 1 |
| 2018 4 | 1 | 1 | 2 |
| 2018 3 | 2 | 2 | 4 |
| 2018 2 | 9 | 0 | 9 |
| 2018 1 | 15 | 1 | 16 |
| 2017 12 | 13 | 0 | 13 |
| 2017 11 | 10 | 0 | 10 |
| 2017 10 | 9 | 0 | 9 |
| 2017 9 | 8 | 0 | 8 |
| 2017 8 | 6 | 2 | 8 |
| 2017 7 | 8 | 0 | 8 |
| 2017 6 | 14 | 0 | 14 |
| 2017 5 | 5 | 0 | 5 |
| 2017 4 | 9 | 1 | 10 |
| 2017 3 | 2 | 1 | 3 |
| 2017 2 | 6 | 1 | 7 |
| 2016 1 | 3 | 1 | 4 |
| 2016 12 | 8 | 9 | 17 |
| 2016 11 | 25 | 29 | 54 |
| 2016 10 | 0 | 3 | 3 |
| 2016 8 | 1 | 1 | 2 |
| 2016 7 | 7 | 13 | 20 |
Mostrar todo
